Contraception Flashcards
Nexplanon
- an implantable rod, which secretes progestin
- effective for three years with a typical and perfect use failure rate of 0.05%, making it the most effective form of contraception available
- functions to thicken the cervical mucus and inhibit ovulation
- the most common side effect is irregular, unpredictable vaginal bleeding but others include weight gain, acne, mood swings, and headache
What is the primary mechanism through which progestin-based contraceptives work?
they thicken the cervical mucus, suppress the endometrium, and inhibit ovulation
Why are IUDs avoided by many women?
because earlier kinds of IUDs were associated with an increased risk of PID and infertility, and even though newer forms are not, the perception persists
Hormonal IUDs
- a T-shaped device implanted in the uterus, which releases small amounts of levonorgestrel, a progestin
- functions by thickening the cervical mucus and suppressing the endometrium
- placement is best performed during menstruation when pregnancy can be excluded and the cervix is slightly dilated; risk of expulsion is 1-5% and most cases occur in the first few months after placement
- effective for up to 5 years with a typical and perfect use failure rate of 0.2%
- added benefit of decreasing menstrual blood loss and severity of dysmenorrhea, possibly inducing amenorrhea
- carries a slight risk of infection in the first 20 days; if pregnancy occurs there is an increased risk of ectopic pregnancy, spontaneous abortion, and preterm labor and delivery
Copper IUD
- a T-shaped device implanted in the uterus, which releases copper ions
- functions as a spermicide, inhibiting both sperm motility and the acrosomal reaction; as emergency contraception, however, it functions by interfering with implantation
- placement is best performed during menstruation when pregnancy can be excluded and the cervix is slightly dilated; risk of expulsion is 1-5% and most cases occur in the first few months after placement
- effective as emergency contraception and for up to 10 years after placement with a typical and perfect failure rate of 0.8 and 0.6%
- side effects include cramps, heavier or longer periods, and spotting between periods
- carries a slight risk of infection in the first 20 days; if pregnancy occurs there is an increased risk of ectopic pregnancy, spontaneous abortion, and preterm labor and delivery
If a patient with an IUD has a positive cervical culture of gonorrhea, chlamydia, or bacterial vaginosis, what is the proper follow up?
- leave the IUD in place and treat the patient
- the IUD only has to be removed if there is evidence of spread to the endometrium or fallopian tubes or if there is failure of the treatment with antibiotics
If a patient with an IUD becomes pregnant what are two next steps?
- ensure that the pregnancy is intrauterine because IUDs increase the proportion of pregnancies that are extrauterine
- remove the IUD if the string is visible since 40-50% of patients spontaneously abort if the IUD is left in place
What are three pregnancy related complications associated with IUDs?
- increased proportion of ectopic pregnancy
- increased risk of first trimester spontaneous abortion
- increased risk of preterm labor and delivery
What is the best time to place an IUD? Why?
during menstruation because this confirms the patient isn’t pregnant and the cervix is usually somewhat dilated during this time
Depot Medroxyprogesterone Acetate
- an injectable progestin given IM or subcutaneously, relying not on sustained-release but on a high peak and sustained levels of hormone
- given every 13 weeks with a 2 week safety margin with a perfect and typical use efficacy of 0.2 and 6%
- functions by thickening the cervical mucus and suppressing endometrial proliferation; it blocks the LH surge but not FSH production, so ovulation is incompletely inhibited
- decreases the risk of endometrial carcinoma and iron deficiency and is helpful in managing pain associated with endometriosis, endometrial hyperplasia, and dysmenorrhea
- may suppress estradiol production and cause loss of bone mineral density; however this is moderate and reversible so there is no recommendation to limit use
- it is the contraceptive mostly strongly linked to weight gain
- has a slower return to fertility than implants or IUDs
- contraindications include known or suspected pregnancy, unevaluated vaginal bleeding, known or suspected breast malignancy, and liver dysfunction or disease
cOCPs
- pills containing ethinyl estradiol and either a 19-nortestosterones or spironolactone derivative
- the progestational component provides most of the contraceptive effect, suppressing the LH surge to inhibit ovulation, thickening the cervical mucus, and suppressing the endometrium; the estrogenic component suppresses FSH secretion and follicle maturation while regulating the cycle
- have a typical use and perfect use efficacy of 9 and 0.3%
- available in traditional or phasic formulations and with a placebo week or as continuous regimens
- have the added benefit of lowering the incidence of endometrial and ovarian cancers, benign breast and ovarian disease, and pelvic infection
- patients may experience breakthrough bleeding due to the shallow and fragile endometrium being prone to asynchronous breakdown and bleeding; usually resolves spontaneously but may offer a week of exogenous estrogen to stabilize the endometrium
- serious complications like DVT, pulmonary embolism, cholestasis and gallbladder disease, strokes and MI are more likely for women using high-dose formulations and in smokers over age 35
- estrogens may also cause a feeling of bloating and weight gain, breast tenderness, nausea, fatigue, or headache
- contraindicated in women over 35 who smoke or have had a thromboembolism and in women with a history of CAD, CHF, cerebral vascular disease, or migraine with aura
cOCPs containing what two hormones?
- ethinyl estradiol
- either a 19-nortestosterone or a spironolactone
What is the role of the estrogen component in cOCPs? What about the role of the progestational component?
- estrogen suppresses FSH and therefore follicle maturation, potentiates the action of the progestational component, improves cycle control by stabilizing the endometrium for more regular cycles with less breakthrough bleeding
- the progestational component provides most of the contraceptive effect by suppressing the LH surge and therefore ovulation, thickening the cervical mucus, and suppressing the endometrium
- in summary, progesterone is for contraception and estrogen is for regulation of the cycle
What is a phasic cOCP?
one in which the ratio of estrogen and progestin varies throughout a pill pack in an effort to lower the total dose of hormones received by the patient
What are continuous cOCPs?
those without a placebo week, which produce shorter or less frequent menstrual periods
Progestin-Only OCPs
- function primarily by thickening the cervical mucus; ovulation continues normally in roughly half of patients
- have a typical and perfect use efficacy of 9 and 0.3%; because the dosages of progestin are so low, scheduled dosing is incredibly important and if a woman is more than 3 hours late, a backup contraceptive method should be used for 48 hours
- most useful in women who are lactating since lactation has the added benefit of suppressing ovulation and in women who are over 40 years old; a good choice for women with contraindications to estrogen
Estrogens have what side effects as hormonal therapy and as contraception?
- they affect lipid metabolism
- potentiate sodium and water retention
- increase renin substrate
- stimulate the CYP450 system
- increase sex hormone-binding globulin
- reduce antithrombin III
Progestins have what side effects?
- increase sebum
- stimulate facial and body hair growth
- induce smooth muscle relaxation
- increase the risk of cholestatic jaundice
What are the contraindications for cOCPs?
- women with a history of migraine with aura, blood clots, estrogen-responsive breast cancer, cerebral vascular disease, CHF, CAD, or liver disease
- women over 35 who smoke or have a history of migraine or hypertension
- women who are breastfeeding
Contraceptive Patch
- a transdermal patch containing synthetic estrogen and progestins
- change every week for three weeks and then leave off for one week to allow for withdrawal bleeding
- typical and perfect use efficacy are 9 and 0.3%, but efficacy is markedly diminished in women weighing more than 198 pounds
- side effects are similar to those of cOCPs with a risk of thrombosis as the primary indication and there is an added risk of skin irritation from the adhesive